AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Tenigly-M Tablet ER

Prescription Icon
Prescription Required

Marketer

Glynis Pharmaceutical Pvt Ltd

Salt Composition

Metformin (500mg) + Teneligliptin (20mg)

Overview Tenigly-M Tablet ER

Duo-Glycemic ER tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Duo-Glycemic ER may be used independently or alongside other antidiabetic therapies. Optimal results require adherence to a healthy diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinue only as directed by your physician. Effective blood sugar control lessens the risk of future complications. Maintaining your prescribed diet and exercise plan is crucial. Lifestyle choices are pivotal in diabetes management. Common side effects include diarrhea, nausea, vomiting, indigestion, and headache. Low blood sugar (hypoglycemia) is a potential side effect, particularly when combined with insulin or sulfonylureas; learn to recognize and manage this. This medication isn't suitable for all individuals. Inform your doctor of any kidney, liver, heart, or pancreatic issues, or excessive alcohol consumption before starting. Pregnant or breastfeeding women should consult their physician. Interactions with other medications are possible; disclose all medications to your doctor. Alcohol should be limited due to its potential to lower blood glucose. Your doctor will monitor your kidney function and blood sugar throughout treatment.

Uses of Tenigly-M Tablet ER

Managing type 2 diabetes

Major Benefits of Tenigly-M Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Tenigly-M Extended-Release tablet whole; do not chew, crush, or divide it. Administer this medicine with a meal.

Common Side effects of Tenigly-M Tablet ER:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Tenigly-M Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Tenigly-M Extended-Release Tablet with a meal.

How Tenigly-M Tablet ER works:

Extended-release Tenigly-M tablets contain a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Tenigly-M Tablet ER and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Tenigly-M tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Tenigly-M tablets are likely unsuitable for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Tenigly-M Tablet ER on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Exercise caution when prescribing Tenigly-M Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended. Tenigly-M Tablet ER is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

The extended-release Tenigly-M tablet is contraindicated in individuals with hepatic impairment and should be avoided. Physician consultation is recommended.

What if you forget to take Tenigly-M Tablet ER :

Should you forget a Tenigly-M Extended-Release Tablet dose, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tenigly-M Tablet ER

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Tenigly-M Tablet ER

Tenigly-M Tablet ER is safe when used as directed by your doctor. However, even with proper use, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar) may occur. Hypoglycemia is more likely if you're also taking insulin or sulfonylurea. Report any persistent issues to your doctor.
Tenigly-M ER tablets rarely cause hypoglycemia by themselves; however, low blood sugar can result from inadequate caloric intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. These symptoms are more pronounced if meals are skipped or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Tenigly-M Tablet ER. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Do not take other medications without your doctor's approval.
Tenigly-M ER tablets are contraindicated in patients allergic to any ingredient. This medication is also harmful for those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Tenigly-M Tablet ER can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect characterized by excessive blood lactic acid. This risk is heightened in individuals with kidney disease, the elderly, and heavy alcohol consumers, so Tenigly-M ER is avoided in these groups. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. If experienced, discontinue Tenigly-M ER and seek immediate medical attention.
Prolonged Tenigly-M Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. If you experience these symptoms, consult your doctor for B12 level monitoring and potential supplementation.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Tenigly-M Tablet ER
113
MRP 131
13% off